首页> 外国专利> ISOBENZOFURANS, A PHARMACEUTICAL COMPOSITION AND AISOBENZOFURANS, A PHARMACEUTICAL COMPOSITION AND A METHOD FOR THE TREATMENT OF DISORDER OR DISEASE S METHOD FOR THE TREATMENT OF DISORDER OR DISEASE SENSIBLE TO THE ACTION OF 5-HT1A ENSIBLE TO THE ACTION OF 5-HT1A

ISOBENZOFURANS, A PHARMACEUTICAL COMPOSITION AND AISOBENZOFURANS, A PHARMACEUTICAL COMPOSITION AND A METHOD FOR THE TREATMENT OF DISORDER OR DISEASE S METHOD FOR THE TREATMENT OF DISORDER OR DISEASE SENSIBLE TO THE ACTION OF 5-HT1A ENSIBLE TO THE ACTION OF 5-HT1A

机译:异丁苯呋喃,一种药物组合物和异丁苯呋喃,一种药物组合物以及一种治疗疾病的方法,该方法用于治疗对5-HT1A作用敏感的5-HT1A作用的疾病

摘要

(I) (1) (2) (3) (4) The present invention relates to benzofuran derivatives having general Formula (I). A is selected from (1), (2), (3), (4) wherein: Z is O or S; s is 0 or 1; q is 0 or 1; R4 is hydrogen, C1-6-alkyl, C2-6-alkenyl, C2-6-alkynyl, C1-6-alkyl-Aryl, or C1-6-alkyl-O-Aryl; D is a spacer group selected from branched or straight chain C1-6-alkylene, C2-6-alkylene and C2-6-alkynylene; its enandomers, and pharmaceutically acceptable acid addition salt thereof. The compounds are potently binding to the 5-HT1A receptor.
机译:(I)(1)(2)(3)(4)本发明涉及具有通式(I)的苯并呋喃衍生物。 A选自(1),(2),(3),(4),其中:Z为O或S; s是0或1; q是0或1; R 4是氢,C 1-6-烷基,C 2-6-烯基,C 2-6-炔基,C 1-6-烷基-芳基或C 1-6-烷基-O-芳基; D是选自支链或直链C1-6亚烷基,C2-6-亚烷基和C2-6-亚炔基的间隔基;其对映体及其药学上可接受的酸加成盐。该化合物有效结合5-HT1A受体。

著录项

  • 公开/公告号UA70347C2

    专利类型

  • 公开/公告日2001-09-17

    原文格式PDF

  • 申请/专利权人 H. LUNDBECK A/S H. LUNDBECK A/S;

    申请/专利号UA19201064499

  • 发明设计人

    申请日1999-12-03

  • 分类号C07D307/87;A61K31/343;

  • 国家 UA

  • 入库时间 2022-08-22 01:23:46

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号